CPIX Cumberland Pharmaceuticals Inc.
Healthcare$5.77-1.70%ClosedMarket Cap: $86.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.06
P/S
2.10
EV/EBITDA
-45.75
DCF Value
$1.02
FCF Yield
1.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
82.9%
Operating Margin
-17.2%
Net Margin
-17.2%
ROE
-28.7%
ROA
-10.2%
ROIC
-19.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $9.1M | 78.8% | $-3.1M | $-3.1M | $— | — |
| Q4 null | $13.7M | 83.6% | $-1.4M | $-1.4M | $— | — |
| FY null | $44.5M | 85.0% | $-2.8M | $-2.8M | $— | — |
| Q3 null | $8.3M | 88.1% | $-2.0M | $-1.9M | $— | — |
| Q2 null | $10.8M | 81.4% | $-747.5K | $-740.7K | $— | — |
| Q1 null | $11.7M | 87.8% | $1.3M | $1.3M | $— | — |
| Q4 null | $10.4M | 81.1% | $-1.8M | $-1.9M | $— | — |
| FY null | $37.9M | 82.6% | $-6.4M | $-6.5M | $— | — |
| Q3 null | $9.1M | 85.4% | $-1.7M | $-1.5M | $— | — |
| Q2 null | $9.8M | 82.6% | $-1.0M | $-1.1M | $— | — |
| Q1 null | $8.5M | 81.5% | $-1.9M | $-1.9M | $— | — |
| Q4 2023 | $9.4M | 83.6% | $-6.2M | $-6.3M | $-0.44 | — |